Leiomyosarcoma classfication: Difference between revisions
Nima Nasiri (talk | contribs) |
Nima Nasiri (talk | contribs) |
||
Line 4: | Line 4: | ||
{{CMG}}; {{AE}}{{Nnasiri}} | {{CMG}}; {{AE}}{{Nnasiri}} | ||
==Overview== | ==Overview== | ||
There is | There is two types of classification for uterine sarcomas, the FIGO (International Federation of Gynecology and Obstetrics) system and the American Joint Committee on Cancer TNM staging system both classifies uterine sarcoma based on T(tumor size), N(spread to nearby lymph nodes) and M(distant metastasis). | ||
==Classification== | ==Classification== | ||
The FIGO (International Federation of Gynecology and Obstetrics) system and the American Joint Committee on Cancer TNM staging system both classifies uterine sarcoma based on T(tumor size), N(spread to nearby lymph nodes) and M(distant metastasis) staging, the table below summarizes the staging of leiomyosarcoma. | The FIGO (International Federation of Gynecology and Obstetrics) system and the American Joint Committee on Cancer TNM staging system both classifies uterine sarcoma based on T(tumor size), N(spread to nearby lymph nodes) and M(distant metastasis) staging, the table below summarizes the staging of leiomyosarcoma. | ||
Stage grouping | Stage grouping |
Revision as of 20:56, 28 February 2019
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Leiomyosarcoma classfication On the Web |
American Roentgen Ray Society Images of Leiomyosarcoma classfication |
Risk calculators and risk factors for Leiomyosarcoma classfication |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
There is two types of classification for uterine sarcomas, the FIGO (International Federation of Gynecology and Obstetrics) system and the American Joint Committee on Cancer TNM staging system both classifies uterine sarcoma based on T(tumor size), N(spread to nearby lymph nodes) and M(distant metastasis).
Classification
The FIGO (International Federation of Gynecology and Obstetrics) system and the American Joint Committee on Cancer TNM staging system both classifies uterine sarcoma based on T(tumor size), N(spread to nearby lymph nodes) and M(distant metastasis) staging, the table below summarizes the staging of leiomyosarcoma.
Stage grouping
FIGO Stage
Stage description*
I
T1
N0
M0
I
The cancer is growing in the uterus, but has not started growing outside the uterus. It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
IA
T1a
N0
M0
IA
The cancer is only in the uterus and is no larger than 5 cm across (about 2 inches) (T1a). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
IB
T1b
N0
M0
IB
The cancer is only in the uterus and is larger than 5 cm across (about 2 inches). (T1b). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
II
T2
N0
M0
II
The cancer is growing outside the uterus but is not growing outside of the pelvis (T2). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
IIIA
T3a
N0
M0
IIIA
The cancer is growing into tissues of the abdomen in one place only (T3a). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
IIIB
T3b
N0
M0
IIIB
The cancer is growing into tissues of the abdomen in 2 or more places (T3b). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
IIIC
T1-T3
N1
M0
IIIC
The cancer is growing in the body of the uterus and it might have spread into tissues of the abdomen, but is not growing into the bladder or rectum (T1 to T3). The cancer has spread to nearby lymph nodes (N1), but not to distant sites (M0).
IVA
T4
Any N
M0
IVA
The cancer has spread to the rectum or urinary bladder (T4). It might or might not have spread to nearby lymph nodes (Any N) but has not spread to distant sites (M0).
IVB
Any T
Any N
M1
IVB
The cancer has spread to distant sites such as the lungs, bones, or liver (M1). The cancer in the uterus can be any size and may or may not have grown into tissues in the pelvis and/or abdomen (including the bladder or rectum) (any T) and it might or might not have spread to nearby lymph nodes (Any N).